TAp63 in pancreas cancer predicts the squamous subtype and promotes a suppressive immune micromilleu

To evaluate the role of aberrant TAp63 in PDAC, we analyzed transcriptomics by RNAseq in the TAp63 and deltaNP63 over-expressing pancreatic cancer cells. A transcriptomic analysis by over-expression of TAP63 and deltaNP63 in the pancreatic cancer cells

为探究异常TAp63在胰腺导管腺癌（PDAC）中的作用，我们通过RNA测序（RNAseq）对过表达TAp63与deltaNP63的胰腺癌细胞开展了转录组学分析。本次转录组学分析针对过表达TAP63与deltaNP63的胰腺癌细胞进行。